These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice? Corrado D; Link MS; Schwartz PJ Eur Heart J; 2022 Aug; 43(32):3029-3040. PubMed ID: 35725934 [TBL] [Abstract][Full Text] [Related]
5. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE; Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848 [No Abstract] [Full Text] [Related]
6. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Dohadwala M; Link MS Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806 [TBL] [Abstract][Full Text] [Related]
7. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
8. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL JACC Clin Electrophysiol; 2021 Nov; 7(11):1437-1472. PubMed ID: 34794667 [TBL] [Abstract][Full Text] [Related]
9. [Primary prevention of sudden cardiac death in 2003. Role of implantable automatic defibrillators]. Mélon P Rev Med Liege; 2003 Jun; 58(6):396-9. PubMed ID: 12945238 [TBL] [Abstract][Full Text] [Related]
10. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines. Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580 [TBL] [Abstract][Full Text] [Related]
11. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy. Goff ZD; Calkins H Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608 [TBL] [Abstract][Full Text] [Related]
12. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695 [No Abstract] [Full Text] [Related]
14. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Von Bergen NH; Wackel PL; Cardiol Young; 2021 Nov; 31(11):1738-1769. PubMed ID: 34338183 [TBL] [Abstract][Full Text] [Related]
15. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL Heart Rhythm; 2021 Nov; 18(11):1888-1924. PubMed ID: 34363988 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis. Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050 [TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
18. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death]. van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359 [TBL] [Abstract][Full Text] [Related]
19. Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies. González-Torrecilla E; Arenal A; Atienza F; Datino T; Bravo L; Ruiz P; Ávila P; Fernández-Avilés F Rev Recent Clin Trials; 2015; 10(2):111-27. PubMed ID: 25845953 [TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death. Berul CI Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S67-70. PubMed ID: 19602167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]